Global Targeted Alpha-particle Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The global Targeted Alpha-particle Therapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Targeted Alpha-particle Therapy Industry Forecast” looks at past sales and reviews total world Targeted Alpha-particle Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Alpha-particle Therapy sales for 2023 through 2029. With Targeted Alpha-particle Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Alpha-particle Therapy industry.
This Insight Report provides a comprehensive analysis of the global Targeted Alpha-particle Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Alpha-particle Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Alpha-particle Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Alpha-particle Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Alpha-particle Therapy.
United States market for Targeted Alpha-particle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted Alpha-particle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted Alpha-particle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted Alpha-particle Therapy players cover Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Alpha-particle Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The global Targeted Alpha-particle Therapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Targeted Alpha-particle Therapy Industry Forecast” looks at past sales and reviews total world Targeted Alpha-particle Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Alpha-particle Therapy sales for 2023 through 2029. With Targeted Alpha-particle Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Alpha-particle Therapy industry.
This Insight Report provides a comprehensive analysis of the global Targeted Alpha-particle Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Alpha-particle Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Alpha-particle Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Alpha-particle Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Alpha-particle Therapy.
United States market for Targeted Alpha-particle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted Alpha-particle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted Alpha-particle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted Alpha-particle Therapy players cover Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Alpha-particle Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Actinium-225
- Astatine-211
- Lead-212
- Bismuth-213
- Others
- Immunotherapy
- Peritoneal Carcinomas
- Bone Metastases
- Leukaemia
- Melanomas
- Solid Tumours
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Actinium-225
- Astatine-211
- Lead-212
- Bismuth-213
- Others
- Immunotherapy
- Peritoneal Carcinomas
- Bone Metastases
- Leukaemia
- Melanomas
- Solid Tumours
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Orano Med
- Oncoinvent AS
- Perspective Therapeutics
- Ablaze Pharma
- ARTBIO
- Fusion Pharmaceuticals(AstraZeneca)
- AlphaGen Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Alpha-particle Therapy Market Size 2019-2030
2.1.2 Targeted Alpha-particle Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Targeted Alpha-particle Therapy by Country/Region, 2019, 2023 & 2030
2.2 Targeted Alpha-particle Therapy Segment by Type
2.2.1 Actinium-225
2.2.2 Astatine-211
2.2.3 Lead-212
2.2.4 Bismuth-213
2.2.5 Others
2.3 Targeted Alpha-particle Therapy Market Size by Type
2.3.1 Targeted Alpha-particle Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
2.4 Targeted Alpha-particle Therapy Segment by Application
2.4.1 Immunotherapy
2.4.2 Peritoneal Carcinomas
2.4.3 Bone Metastases
2.4.4 Leukaemia
2.4.5 Melanomas
2.4.6 Solid Tumours
2.5 Targeted Alpha-particle Therapy Market Size by Application
2.5.1 Targeted Alpha-particle Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
3 TARGETED ALPHA-PARTICLE THERAPY MARKET SIZE BY PLAYER
3.1 Targeted Alpha-particle Therapy Market Size Market Share by Player
3.1.1 Global Targeted Alpha-particle Therapy Revenue by Player (2019-2024)
3.1.2 Global Targeted Alpha-particle Therapy Revenue Market Share by Player (2019-2024)
3.2 Global Targeted Alpha-particle Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED ALPHA-PARTICLE THERAPY BY REGION
4.1 Targeted Alpha-particle Therapy Market Size by Region (2019-2024)
4.2 Global Targeted Alpha-particle Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted Alpha-particle Therapy Market Size Growth (2019-2024)
4.4 APAC Targeted Alpha-particle Therapy Market Size Growth (2019-2024)
4.5 Europe Targeted Alpha-particle Therapy Market Size Growth (2019-2024)
4.6 Middle East & Africa Targeted Alpha-particle Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Targeted Alpha-particle Therapy Market Size by Country (2019-2024)
5.2 Americas Targeted Alpha-particle Therapy Market Size by Type (2019-2024)
5.3 Americas Targeted Alpha-particle Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Alpha-particle Therapy Market Size by Region (2019-2024)
6.2 APAC Targeted Alpha-particle Therapy Market Size by Type (2019-2024)
6.3 APAC Targeted Alpha-particle Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024)
7.2 Europe Targeted Alpha-particle Therapy Market Size by Type (2019-2024)
7.3 Europe Targeted Alpha-particle Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Alpha-particle Therapy by Region (2019-2024)
8.2 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED ALPHA-PARTICLE THERAPY MARKET FORECAST
10.1 Global Targeted Alpha-particle Therapy Forecast by Region (2025-2030)
10.1.1 Global Targeted Alpha-particle Therapy Forecast by Region (2025-2030)
10.1.2 Americas Targeted Alpha-particle Therapy Forecast
10.1.3 APAC Targeted Alpha-particle Therapy Forecast
10.1.4 Europe Targeted Alpha-particle Therapy Forecast
10.1.5 Middle East & Africa Targeted Alpha-particle Therapy Forecast
10.2 Americas Targeted Alpha-particle Therapy Forecast by Country (2025-2030)
10.2.1 United States Market Targeted Alpha-particle Therapy Forecast
10.2.2 Canada Market Targeted Alpha-particle Therapy Forecast
10.2.3 Mexico Market Targeted Alpha-particle Therapy Forecast
10.2.4 Brazil Market Targeted Alpha-particle Therapy Forecast
10.3 APAC Targeted Alpha-particle Therapy Forecast by Region (2025-2030)
10.3.1 China Targeted Alpha-particle Therapy Market Forecast
10.3.2 Japan Market Targeted Alpha-particle Therapy Forecast
10.3.3 Korea Market Targeted Alpha-particle Therapy Forecast
10.3.4 Southeast Asia Market Targeted Alpha-particle Therapy Forecast
10.3.5 India Market Targeted Alpha-particle Therapy Forecast
10.3.6 Australia Market Targeted Alpha-particle Therapy Forecast
10.4 Europe Targeted Alpha-particle Therapy Forecast by Country (2025-2030)
10.4.1 Germany Market Targeted Alpha-particle Therapy Forecast
10.4.2 France Market Targeted Alpha-particle Therapy Forecast
10.4.3 UK Market Targeted Alpha-particle Therapy Forecast
10.4.4 Italy Market Targeted Alpha-particle Therapy Forecast
10.4.5 Russia Market Targeted Alpha-particle Therapy Forecast
10.5 Middle East & Africa Targeted Alpha-particle Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Market Targeted Alpha-particle Therapy Forecast
10.5.2 South Africa Market Targeted Alpha-particle Therapy Forecast
10.5.3 Israel Market Targeted Alpha-particle Therapy Forecast
10.5.4 Turkey Market Targeted Alpha-particle Therapy Forecast
10.6 Global Targeted Alpha-particle Therapy Forecast by Type (2025-2030)
10.7 Global Targeted Alpha-particle Therapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Targeted Alpha-particle Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Targeted Alpha-particle Therapy Product Offered
11.1.3 Bayer Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Orano Med
11.2.1 Orano Med Company Information
11.2.2 Orano Med Targeted Alpha-particle Therapy Product Offered
11.2.3 Orano Med Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Orano Med Main Business Overview
11.2.5 Orano Med Latest Developments
11.3 Oncoinvent AS
11.3.1 Oncoinvent AS Company Information
11.3.2 Oncoinvent AS Targeted Alpha-particle Therapy Product Offered
11.3.3 Oncoinvent AS Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Oncoinvent AS Main Business Overview
11.3.5 Oncoinvent AS Latest Developments
11.4 Perspective Therapeutics
11.4.1 Perspective Therapeutics Company Information
11.4.2 Perspective Therapeutics Targeted Alpha-particle Therapy Product Offered
11.4.3 Perspective Therapeutics Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Perspective Therapeutics Main Business Overview
11.4.5 Perspective Therapeutics Latest Developments
11.5 Ablaze Pharma
11.5.1 Ablaze Pharma Company Information
11.5.2 Ablaze Pharma Targeted Alpha-particle Therapy Product Offered
11.5.3 Ablaze Pharma Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Ablaze Pharma Main Business Overview
11.5.5 Ablaze Pharma Latest Developments
11.6 ARTBIO
11.6.1 ARTBIO Company Information
11.6.2 ARTBIO Targeted Alpha-particle Therapy Product Offered
11.6.3 ARTBIO Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ARTBIO Main Business Overview
11.6.5 ARTBIO Latest Developments
11.7 Fusion Pharmaceuticals(AstraZeneca)
11.7.1 Fusion Pharmaceuticals(AstraZeneca) Company Information
11.7.2 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Offered
11.7.3 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fusion Pharmaceuticals(AstraZeneca) Main Business Overview
11.7.5 Fusion Pharmaceuticals(AstraZeneca) Latest Developments
11.8 AlphaGen Therapeutics
11.8.1 AlphaGen Therapeutics Company Information
11.8.2 AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Offered
11.8.3 AlphaGen Therapeutics Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AlphaGen Therapeutics Main Business Overview
11.8.5 AlphaGen Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Alpha-particle Therapy Market Size 2019-2030
2.1.2 Targeted Alpha-particle Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Targeted Alpha-particle Therapy by Country/Region, 2019, 2023 & 2030
2.2 Targeted Alpha-particle Therapy Segment by Type
2.2.1 Actinium-225
2.2.2 Astatine-211
2.2.3 Lead-212
2.2.4 Bismuth-213
2.2.5 Others
2.3 Targeted Alpha-particle Therapy Market Size by Type
2.3.1 Targeted Alpha-particle Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
2.4 Targeted Alpha-particle Therapy Segment by Application
2.4.1 Immunotherapy
2.4.2 Peritoneal Carcinomas
2.4.3 Bone Metastases
2.4.4 Leukaemia
2.4.5 Melanomas
2.4.6 Solid Tumours
2.5 Targeted Alpha-particle Therapy Market Size by Application
2.5.1 Targeted Alpha-particle Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
3 TARGETED ALPHA-PARTICLE THERAPY MARKET SIZE BY PLAYER
3.1 Targeted Alpha-particle Therapy Market Size Market Share by Player
3.1.1 Global Targeted Alpha-particle Therapy Revenue by Player (2019-2024)
3.1.2 Global Targeted Alpha-particle Therapy Revenue Market Share by Player (2019-2024)
3.2 Global Targeted Alpha-particle Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED ALPHA-PARTICLE THERAPY BY REGION
4.1 Targeted Alpha-particle Therapy Market Size by Region (2019-2024)
4.2 Global Targeted Alpha-particle Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted Alpha-particle Therapy Market Size Growth (2019-2024)
4.4 APAC Targeted Alpha-particle Therapy Market Size Growth (2019-2024)
4.5 Europe Targeted Alpha-particle Therapy Market Size Growth (2019-2024)
4.6 Middle East & Africa Targeted Alpha-particle Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Targeted Alpha-particle Therapy Market Size by Country (2019-2024)
5.2 Americas Targeted Alpha-particle Therapy Market Size by Type (2019-2024)
5.3 Americas Targeted Alpha-particle Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Alpha-particle Therapy Market Size by Region (2019-2024)
6.2 APAC Targeted Alpha-particle Therapy Market Size by Type (2019-2024)
6.3 APAC Targeted Alpha-particle Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024)
7.2 Europe Targeted Alpha-particle Therapy Market Size by Type (2019-2024)
7.3 Europe Targeted Alpha-particle Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Alpha-particle Therapy by Region (2019-2024)
8.2 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED ALPHA-PARTICLE THERAPY MARKET FORECAST
10.1 Global Targeted Alpha-particle Therapy Forecast by Region (2025-2030)
10.1.1 Global Targeted Alpha-particle Therapy Forecast by Region (2025-2030)
10.1.2 Americas Targeted Alpha-particle Therapy Forecast
10.1.3 APAC Targeted Alpha-particle Therapy Forecast
10.1.4 Europe Targeted Alpha-particle Therapy Forecast
10.1.5 Middle East & Africa Targeted Alpha-particle Therapy Forecast
10.2 Americas Targeted Alpha-particle Therapy Forecast by Country (2025-2030)
10.2.1 United States Market Targeted Alpha-particle Therapy Forecast
10.2.2 Canada Market Targeted Alpha-particle Therapy Forecast
10.2.3 Mexico Market Targeted Alpha-particle Therapy Forecast
10.2.4 Brazil Market Targeted Alpha-particle Therapy Forecast
10.3 APAC Targeted Alpha-particle Therapy Forecast by Region (2025-2030)
10.3.1 China Targeted Alpha-particle Therapy Market Forecast
10.3.2 Japan Market Targeted Alpha-particle Therapy Forecast
10.3.3 Korea Market Targeted Alpha-particle Therapy Forecast
10.3.4 Southeast Asia Market Targeted Alpha-particle Therapy Forecast
10.3.5 India Market Targeted Alpha-particle Therapy Forecast
10.3.6 Australia Market Targeted Alpha-particle Therapy Forecast
10.4 Europe Targeted Alpha-particle Therapy Forecast by Country (2025-2030)
10.4.1 Germany Market Targeted Alpha-particle Therapy Forecast
10.4.2 France Market Targeted Alpha-particle Therapy Forecast
10.4.3 UK Market Targeted Alpha-particle Therapy Forecast
10.4.4 Italy Market Targeted Alpha-particle Therapy Forecast
10.4.5 Russia Market Targeted Alpha-particle Therapy Forecast
10.5 Middle East & Africa Targeted Alpha-particle Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Market Targeted Alpha-particle Therapy Forecast
10.5.2 South Africa Market Targeted Alpha-particle Therapy Forecast
10.5.3 Israel Market Targeted Alpha-particle Therapy Forecast
10.5.4 Turkey Market Targeted Alpha-particle Therapy Forecast
10.6 Global Targeted Alpha-particle Therapy Forecast by Type (2025-2030)
10.7 Global Targeted Alpha-particle Therapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Targeted Alpha-particle Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Targeted Alpha-particle Therapy Product Offered
11.1.3 Bayer Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Orano Med
11.2.1 Orano Med Company Information
11.2.2 Orano Med Targeted Alpha-particle Therapy Product Offered
11.2.3 Orano Med Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Orano Med Main Business Overview
11.2.5 Orano Med Latest Developments
11.3 Oncoinvent AS
11.3.1 Oncoinvent AS Company Information
11.3.2 Oncoinvent AS Targeted Alpha-particle Therapy Product Offered
11.3.3 Oncoinvent AS Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Oncoinvent AS Main Business Overview
11.3.5 Oncoinvent AS Latest Developments
11.4 Perspective Therapeutics
11.4.1 Perspective Therapeutics Company Information
11.4.2 Perspective Therapeutics Targeted Alpha-particle Therapy Product Offered
11.4.3 Perspective Therapeutics Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Perspective Therapeutics Main Business Overview
11.4.5 Perspective Therapeutics Latest Developments
11.5 Ablaze Pharma
11.5.1 Ablaze Pharma Company Information
11.5.2 Ablaze Pharma Targeted Alpha-particle Therapy Product Offered
11.5.3 Ablaze Pharma Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Ablaze Pharma Main Business Overview
11.5.5 Ablaze Pharma Latest Developments
11.6 ARTBIO
11.6.1 ARTBIO Company Information
11.6.2 ARTBIO Targeted Alpha-particle Therapy Product Offered
11.6.3 ARTBIO Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ARTBIO Main Business Overview
11.6.5 ARTBIO Latest Developments
11.7 Fusion Pharmaceuticals(AstraZeneca)
11.7.1 Fusion Pharmaceuticals(AstraZeneca) Company Information
11.7.2 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Offered
11.7.3 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fusion Pharmaceuticals(AstraZeneca) Main Business Overview
11.7.5 Fusion Pharmaceuticals(AstraZeneca) Latest Developments
11.8 AlphaGen Therapeutics
11.8.1 AlphaGen Therapeutics Company Information
11.8.2 AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Offered
11.8.3 AlphaGen Therapeutics Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AlphaGen Therapeutics Main Business Overview
11.8.5 AlphaGen Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Alpha-particle Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Targeted Alpha-particle Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Actinium-225
Table 4. Major Players of Astatine-211
Table 5. Major Players of Lead-212
Table 6. Major Players of Bismuth-213
Table 7. Major Players of Others
Table 8. Targeted Alpha-particle Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 10. Global Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Table 11. Targeted Alpha-particle Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 13. Global Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Table 14. Global Targeted Alpha-particle Therapy Revenue by Player (2019-2024) & ($ millions)
Table 15. Global Targeted Alpha-particle Therapy Revenue Market Share by Player (2019-2024)
Table 16. Targeted Alpha-particle Therapy Key Players Head office and Products Offered
Table 17. Targeted Alpha-particle Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions)
Table 21. Global Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024)
Table 22. Global Targeted Alpha-particle Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Targeted Alpha-particle Therapy Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & ($ millions)
Table 25. Americas Targeted Alpha-particle Therapy Market Size Market Share by Country (2019-2024)
Table 26. Americas Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 27. Americas Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Table 28. Americas Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 29. Americas Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Table 30. APAC Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions)
Table 31. APAC Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024)
Table 32. APAC Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 33. APAC Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 34. Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & ($ millions)
Table 35. Europe Targeted Alpha-particle Therapy Market Size Market Share by Country (2019-2024)
Table 36. Europe Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 37. Europe Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 38. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions)
Table 39. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 40. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Targeted Alpha-particle Therapy
Table 42. Key Market Challenges & Risks of Targeted Alpha-particle Therapy
Table 43. Key Industry Trends of Targeted Alpha-particle Therapy
Table 44. Global Targeted Alpha-particle Therapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 45. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Region (2025-2030)
Table 46. Global Targeted Alpha-particle Therapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 47. Global Targeted Alpha-particle Therapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 48. Bayer Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 49. Bayer Targeted Alpha-particle Therapy Product Offered
Table 50. Bayer Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 51. Bayer Main Business
Table 52. Bayer Latest Developments
Table 53. Orano Med Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 54. Orano Med Targeted Alpha-particle Therapy Product Offered
Table 55. Orano Med Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Orano Med Main Business
Table 57. Orano Med Latest Developments
Table 58. Oncoinvent AS Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 59. Oncoinvent AS Targeted Alpha-particle Therapy Product Offered
Table 60. Oncoinvent AS Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Oncoinvent AS Main Business
Table 62. Oncoinvent AS Latest Developments
Table 63. Perspective Therapeutics Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 64. Perspective Therapeutics Targeted Alpha-particle Therapy Product Offered
Table 65. Perspective Therapeutics Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Perspective Therapeutics Main Business
Table 67. Perspective Therapeutics Latest Developments
Table 68. Ablaze Pharma Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 69. Ablaze Pharma Targeted Alpha-particle Therapy Product Offered
Table 70. Ablaze Pharma Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Ablaze Pharma Main Business
Table 72. Ablaze Pharma Latest Developments
Table 73. ARTBIO Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 74. ARTBIO Targeted Alpha-particle Therapy Product Offered
Table 75. ARTBIO Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. ARTBIO Main Business
Table 77. ARTBIO Latest Developments
Table 78. Fusion Pharmaceuticals(AstraZeneca) Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 79. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Offered
Table 80. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Fusion Pharmaceuticals(AstraZeneca) Main Business
Table 82. Fusion Pharmaceuticals(AstraZeneca) Latest Developments
Table 83. AlphaGen Therapeutics Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 84. AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Offered
Table 85. AlphaGen Therapeutics Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. AlphaGen Therapeutics Main Business
Table 87. AlphaGen Therapeutics Latest Developments
Table 1. Targeted Alpha-particle Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Targeted Alpha-particle Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Actinium-225
Table 4. Major Players of Astatine-211
Table 5. Major Players of Lead-212
Table 6. Major Players of Bismuth-213
Table 7. Major Players of Others
Table 8. Targeted Alpha-particle Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 10. Global Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Table 11. Targeted Alpha-particle Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 13. Global Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Table 14. Global Targeted Alpha-particle Therapy Revenue by Player (2019-2024) & ($ millions)
Table 15. Global Targeted Alpha-particle Therapy Revenue Market Share by Player (2019-2024)
Table 16. Targeted Alpha-particle Therapy Key Players Head office and Products Offered
Table 17. Targeted Alpha-particle Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions)
Table 21. Global Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024)
Table 22. Global Targeted Alpha-particle Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Targeted Alpha-particle Therapy Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & ($ millions)
Table 25. Americas Targeted Alpha-particle Therapy Market Size Market Share by Country (2019-2024)
Table 26. Americas Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 27. Americas Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Table 28. Americas Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 29. Americas Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Table 30. APAC Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions)
Table 31. APAC Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024)
Table 32. APAC Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 33. APAC Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 34. Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & ($ millions)
Table 35. Europe Targeted Alpha-particle Therapy Market Size Market Share by Country (2019-2024)
Table 36. Europe Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 37. Europe Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 38. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions)
Table 39. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions)
Table 40. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Targeted Alpha-particle Therapy
Table 42. Key Market Challenges & Risks of Targeted Alpha-particle Therapy
Table 43. Key Industry Trends of Targeted Alpha-particle Therapy
Table 44. Global Targeted Alpha-particle Therapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 45. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Region (2025-2030)
Table 46. Global Targeted Alpha-particle Therapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 47. Global Targeted Alpha-particle Therapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 48. Bayer Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 49. Bayer Targeted Alpha-particle Therapy Product Offered
Table 50. Bayer Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 51. Bayer Main Business
Table 52. Bayer Latest Developments
Table 53. Orano Med Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 54. Orano Med Targeted Alpha-particle Therapy Product Offered
Table 55. Orano Med Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Orano Med Main Business
Table 57. Orano Med Latest Developments
Table 58. Oncoinvent AS Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 59. Oncoinvent AS Targeted Alpha-particle Therapy Product Offered
Table 60. Oncoinvent AS Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Oncoinvent AS Main Business
Table 62. Oncoinvent AS Latest Developments
Table 63. Perspective Therapeutics Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 64. Perspective Therapeutics Targeted Alpha-particle Therapy Product Offered
Table 65. Perspective Therapeutics Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Perspective Therapeutics Main Business
Table 67. Perspective Therapeutics Latest Developments
Table 68. Ablaze Pharma Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 69. Ablaze Pharma Targeted Alpha-particle Therapy Product Offered
Table 70. Ablaze Pharma Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Ablaze Pharma Main Business
Table 72. Ablaze Pharma Latest Developments
Table 73. ARTBIO Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 74. ARTBIO Targeted Alpha-particle Therapy Product Offered
Table 75. ARTBIO Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. ARTBIO Main Business
Table 77. ARTBIO Latest Developments
Table 78. Fusion Pharmaceuticals(AstraZeneca) Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 79. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Offered
Table 80. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Fusion Pharmaceuticals(AstraZeneca) Main Business
Table 82. Fusion Pharmaceuticals(AstraZeneca) Latest Developments
Table 83. AlphaGen Therapeutics Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors
Table 84. AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Offered
Table 85. AlphaGen Therapeutics Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. AlphaGen Therapeutics Main Business
Table 87. AlphaGen Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Targeted Alpha-particle Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Alpha-particle Therapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Targeted Alpha-particle Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Targeted Alpha-particle Therapy Sales Market Share by Country/Region (2023)
Figure 8. Targeted Alpha-particle Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Targeted Alpha-particle Therapy Market Size Market Share by Type in 2023
Figure 10. Targeted Alpha-particle Therapy in Immunotherapy
Figure 11. Global Targeted Alpha-particle Therapy Market: Immunotherapy (2019-2024) & ($ millions)
Figure 12. Targeted Alpha-particle Therapy in Peritoneal Carcinomas
Figure 13. Global Targeted Alpha-particle Therapy Market: Peritoneal Carcinomas (2019-2024) & ($ millions)
Figure 14. Targeted Alpha-particle Therapy in Bone Metastases
Figure 15. Global Targeted Alpha-particle Therapy Market: Bone Metastases (2019-2024) & ($ millions)
Figure 16. Targeted Alpha-particle Therapy in Leukaemia
Figure 17. Global Targeted Alpha-particle Therapy Market: Leukaemia (2019-2024) & ($ millions)
Figure 18. Targeted Alpha-particle Therapy in Melanomas
Figure 19. Global Targeted Alpha-particle Therapy Market: Melanomas (2019-2024) & ($ millions)
Figure 20. Targeted Alpha-particle Therapy in Solid Tumours
Figure 21. Global Targeted Alpha-particle Therapy Market: Solid Tumours (2019-2024) & ($ millions)
Figure 22. Global Targeted Alpha-particle Therapy Market Size Market Share by Application in 2023
Figure 23. Global Targeted Alpha-particle Therapy Revenue Market Share by Player in 2023
Figure 24. Global Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024)
Figure 25. Americas Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions)
Figure 26. APAC Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions)
Figure 27. Europe Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions)
Figure 28. Middle East & Africa Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions)
Figure 29. Americas Targeted Alpha-particle Therapy Value Market Share by Country in 2023
Figure 30. United States Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 31. Canada Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 32. Mexico Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 33. Brazil Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 34. APAC Targeted Alpha-particle Therapy Market Size Market Share by Region in 2023
Figure 35. APAC Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Figure 36. APAC Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Figure 37. China Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 38. Japan Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 39. South Korea Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 40. Southeast Asia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 41. India Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 42. Australia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 43. Europe Targeted Alpha-particle Therapy Market Size Market Share by Country in 2023
Figure 44. Europe Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Figure 45. Europe Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Figure 46. Germany Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 47. France Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 48. UK Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 49. Italy Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 50. Russia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 51. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 55. South Africa Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 56. Israel Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 57. Turkey Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 58. GCC Countries Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 59. Americas Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 60. APAC Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 61. Europe Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 62. Middle East & Africa Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 63. United States Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 64. Canada Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 65. Mexico Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 66. Brazil Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 67. China Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 68. Japan Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 69. Korea Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 70. Southeast Asia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 71. India Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 72. Australia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 73. Germany Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 74. France Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 75. UK Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 76. Italy Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 77. Russia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 78. Egypt Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 79. South Africa Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 80. Israel Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 81. Turkey Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 82. GCC Countries Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 83. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 84. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Targeted Alpha-particle Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Alpha-particle Therapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Targeted Alpha-particle Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Targeted Alpha-particle Therapy Sales Market Share by Country/Region (2023)
Figure 8. Targeted Alpha-particle Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Targeted Alpha-particle Therapy Market Size Market Share by Type in 2023
Figure 10. Targeted Alpha-particle Therapy in Immunotherapy
Figure 11. Global Targeted Alpha-particle Therapy Market: Immunotherapy (2019-2024) & ($ millions)
Figure 12. Targeted Alpha-particle Therapy in Peritoneal Carcinomas
Figure 13. Global Targeted Alpha-particle Therapy Market: Peritoneal Carcinomas (2019-2024) & ($ millions)
Figure 14. Targeted Alpha-particle Therapy in Bone Metastases
Figure 15. Global Targeted Alpha-particle Therapy Market: Bone Metastases (2019-2024) & ($ millions)
Figure 16. Targeted Alpha-particle Therapy in Leukaemia
Figure 17. Global Targeted Alpha-particle Therapy Market: Leukaemia (2019-2024) & ($ millions)
Figure 18. Targeted Alpha-particle Therapy in Melanomas
Figure 19. Global Targeted Alpha-particle Therapy Market: Melanomas (2019-2024) & ($ millions)
Figure 20. Targeted Alpha-particle Therapy in Solid Tumours
Figure 21. Global Targeted Alpha-particle Therapy Market: Solid Tumours (2019-2024) & ($ millions)
Figure 22. Global Targeted Alpha-particle Therapy Market Size Market Share by Application in 2023
Figure 23. Global Targeted Alpha-particle Therapy Revenue Market Share by Player in 2023
Figure 24. Global Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024)
Figure 25. Americas Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions)
Figure 26. APAC Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions)
Figure 27. Europe Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions)
Figure 28. Middle East & Africa Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions)
Figure 29. Americas Targeted Alpha-particle Therapy Value Market Share by Country in 2023
Figure 30. United States Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 31. Canada Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 32. Mexico Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 33. Brazil Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 34. APAC Targeted Alpha-particle Therapy Market Size Market Share by Region in 2023
Figure 35. APAC Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Figure 36. APAC Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Figure 37. China Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 38. Japan Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 39. South Korea Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 40. Southeast Asia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 41. India Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 42. Australia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 43. Europe Targeted Alpha-particle Therapy Market Size Market Share by Country in 2023
Figure 44. Europe Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Figure 45. Europe Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Figure 46. Germany Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 47. France Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 48. UK Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 49. Italy Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 50. Russia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 51. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 55. South Africa Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 56. Israel Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 57. Turkey Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 58. GCC Countries Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions)
Figure 59. Americas Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 60. APAC Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 61. Europe Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 62. Middle East & Africa Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 63. United States Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 64. Canada Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 65. Mexico Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 66. Brazil Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 67. China Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 68. Japan Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 69. Korea Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 70. Southeast Asia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 71. India Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 72. Australia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 73. Germany Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 74. France Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 75. UK Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 76. Italy Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 77. Russia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 78. Egypt Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 79. South Africa Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 80. Israel Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 81. Turkey Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 82. GCC Countries Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions)
Figure 83. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 84. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Application (2025-2030)
